LSL Pharma Group Inc (TSE:LSL) has released an update.
LSL Pharma Group Inc. has announced a significant change in their financial oversight by appointing Audacie Inc. as their new auditor, following the resignation of their previous auditor, KPMG LLP. Additionally, the pharmaceutical corporation has granted over 460,000 stock options to officers and directors, which will vest over a three-year period and have a ten-year term.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.
